Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crotty

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|April 23, 2015
Infectious mononucleosisPaul Lennon, Michael Crotty, John E Fenton
Expert Opinion on Pharmacotherapy|December 6, 2025
Tirzepatide vs. semaglutide: clinical decision-making in the GLP-1 landscapeAlvin Mondoh, Michael Crotty, Carel W le Roux
Diabetes, Obesity & Metabolism|June 16, 2025
Why do patients with obesity discontinue glucagon-like peptide 1 analogues?Faisal I Almohaileb, Carel W le Roux, Michael Crotty
The International Zoo Yearbook|April 28, 2020
An historical overview of selected rare ruminants in captivityWarren D Thomas, Robert Barnes, Michael Crotty, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2026
Implementation of a pharmacy technician medication history service at a pediatric health systemKathryn Schwaller, Nicholas Michel, Michael Crotty, et al.
Journal of Healthcare Leadership|May 6, 2026
Leadership in Obesity Care: Strategies to Support Healthcare Professionals in Effective Decisions, Communication, and Solutions - A Scoping ReviewAnne Moorhead, Louise Lynch, Fiona Quigley, et al.
Obesity Pillars|July 17, 2025
How do patients choose between obesity medications: A thematic analysisAlvin Mondoh, Hilary Craig, Michael Crotty, et al.
Obesity Pillars|March 12, 2026
Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussionsAlvin Mondoh, Francisca Contreras, Hilary Craig, et al.
Obesity Pillars|March 2, 2026
Logistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysisAlvin Mondoh, Francisca Contreras, Hilary Craig, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 11, 2024
'Beyond the Scale': A Qualitative Exploration of the Impact of Weight Stigma Experienced by Patients With Obesity in General PracticeLeona Ryan, Fiona Quigley, Susie Birney, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|April 23, 2015
Infectious mononucleosisPaul Lennon, Michael Crotty, John E Fenton
Expert Opinion on Pharmacotherapy|December 6, 2025
Tirzepatide vs. semaglutide: clinical decision-making in the GLP-1 landscapeAlvin Mondoh, Michael Crotty, Carel W le Roux
Diabetes, Obesity & Metabolism|June 16, 2025
Why do patients with obesity discontinue glucagon-like peptide 1 analogues?Faisal I Almohaileb, Carel W le Roux, Michael Crotty
The International Zoo Yearbook|April 28, 2020
An historical overview of selected rare ruminants in captivityWarren D Thomas, Robert Barnes, Michael Crotty, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2026
Implementation of a pharmacy technician medication history service at a pediatric health systemKathryn Schwaller, Nicholas Michel, Michael Crotty, et al.
Journal of Healthcare Leadership|May 6, 2026
Leadership in Obesity Care: Strategies to Support Healthcare Professionals in Effective Decisions, Communication, and Solutions - A Scoping ReviewAnne Moorhead, Louise Lynch, Fiona Quigley, et al.
Obesity Pillars|July 17, 2025
How do patients choose between obesity medications: A thematic analysisAlvin Mondoh, Hilary Craig, Michael Crotty, et al.
Obesity Pillars|March 12, 2026
Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussionsAlvin Mondoh, Francisca Contreras, Hilary Craig, et al.
Obesity Pillars|March 2, 2026
Logistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysisAlvin Mondoh, Francisca Contreras, Hilary Craig, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 11, 2024
'Beyond the Scale': A Qualitative Exploration of the Impact of Weight Stigma Experienced by Patients With Obesity in General PracticeLeona Ryan, Fiona Quigley, Susie Birney, et al.
Pageof 2